News | Stents Drug Eluting | February 19, 2018
February 19, 2018 — The Detroit Medical Center’s (DMC) interventional cardiology team at Heart Hospital recently beca
Technology | Stents Drug Eluting | December 13, 2017
Cordis, a Cardinal Health company, and Medinol recently announced U.S. Food and Drug Administration (FDA) approval of...
News | Stents | November 10, 2017
Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology portfolio, which now...
News | Stents Drug Eluting | January 10, 2017
Medinol announced in December positive twelve-month clinical results from the BIONICS study. The study was conducted to...
News | Stents | November 07, 2016
November 7, 2016 – The large multinational randomized BIONICS study found that a novel elastic polymer coated ridafor
News | Stents | March 24, 2016
March 24, 2016 — Medinol announced the enrollment of their first patient in the U.S. NIRTRAKS Study.
Technology | Stents Bare Metal | December 09, 2015
Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the launch of the...
News | Stents | October 26, 2015
Medinol announced in September the completion of enrollment in its BIONICS trial to evaluate the safety and...
News | June 10, 2014
Ariad, Medinol Undergoing Two Trials of NIRsupreme Ridaforolimus-Eluting Stent for Coronary Artery Disease
June 10, 2014 — Ariad Pharmaceuticals Inc. and Medinol Ltd. earlier this year initiated two registration trials of...